In human malignancies such as gastric, colorectal cancer, NSCLC (non-small-cell lung carcinoma), hepatocellular carcinoma, and others, NEDD4 is commonly overexpressed and is an important factor in medication resistance during cancer treatment. The gene discussed is NEDD4; the disease is hepatocellular carcinoma.